Malignant Diseases Associated with COVID-19 Infection

The COVID-19 pandemic has had significant implications for patients with malignant diseases, revealing complex interactions between viral infection and cancer. This review explores the association of COVID-19 infection with various malignant diseases, including hematological malignancies and solid tumors. Potential mechanisms underlying this association include immune dysregulation, chronic inflammation, and alterations in the tumor microenvironment. Additionally, the pandemic has disrupted cancer care, leading to delays in diagnosis and treatment while increasing the vulnerability of cancer patients to severe COVID-19 outcomes. The review emphasizes the need for enhanced cancer care protocols, ongoing research into the long-term effects of COVID-19 on cancer progression, and support for the psychosocial needs of patients. By addressing these challenges, the healthcare community can improve patient outcomes and develop effective strategies for managing malignant diseases in the context of a global pandemic.